Skip to main content
Ira Tabas, MD, Endocrinology, New York, NY, New York-Presbyterian Hospital

IraA.TabasMD

Endocrinology • New York, NY

Diabetes, Lipid Metabolism

Professor, Medicine, Columbia University College of Phys & Surg

Join to view full profile

Dr. Tabas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Tabas' full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1981 - 1983
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1981

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1982 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1992

Publications & Presentations

PubMed

Journal Articles

  • JACC Focus Seminar: Macrophage in CVD Series JACC Focus Seminar Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis: JACC Macrophage in CV...  
    Amanda C Doran, Jason C Kovacic, Edward A Fisher, Ira Tabas, ScienceDirect
  • A New Activator of Hepatocyte CaMKII in Fasting and Type 2 Diabetes  
    Ira Tabas, MD, Diabetes Care

Abstracts/Posters

  • The Markedly Increased PAI1 in Obesity Induces a Compensatory Increase of Hepatocyte Tpa Expression By Activating a LRP1-CREB1 Pathway
    Ira Tabas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Hepatocyte-Derived Tissue Plasminogen Activator Regulates Systemic Fibrinolysis 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Possible Unexpected Atherosclerosis Treatment
    Possible Unexpected Atherosclerosis TreatmentJanuary 31st, 2020
  • Putrescine Could Be a Therapy for Chronic Inflammatory Diseases
    Putrescine Could Be a Therapy for Chronic Inflammatory DiseasesJanuary 31st, 2020
  • 'Stench of Death' Compound Helps Your Body Feast on Its Own Rotting Cells
    'Stench of Death' Compound Helps Your Body Feast on Its Own Rotting CellsJanuary 31st, 2020
  • Join now to see all

Grant Support

  • Mechanisms Of Defective Efferocytosis In AtherosclerosisNational Heart, Lung, And Blood Institute2012
  • Autophagy In Advanced AtherosclerosisNational Heart, Lung, And Blood Institute2011–2012
  • The Unfolded Protein Response In Sterol CytoxicityNational Heart, Lung, And Blood Institute2005–2012
  • Role Of Camkii In Hepatic GluconeogenesisNational Center For Research Resources2011
  • Molecular Links Between Insulin Resistance And Macrophage Death In AtherosclerosiNational Heart, Lung, And Blood Institute2007–2011
  • Mechanisms Of Atherogenesis In Insulin ResistanceNational Heart, Lung, And Blood Institute2007–2011
  • Administrative CoreNational Heart, Lung, And Blood Institute2007–2011
  • 2010 Lipoprotein Metabolism GrcNational Heart, Lung, And Blood Institute2010
  • Macrophage Death In Plaque VulnerabilityNational Heart, Lung, And Blood Institute2006–2010
  • Interaction Of Atherogenic Lipoproteins With MacrophagesNational Heart, Lung, And Blood Institute1997–2010
  • The Unfolded Protein Response In Sterol CytotoxicityNational Heart, Lung, And Blood Institute2004–2007
  • Core D--PathologyNational Heart, Lung, And Blood Institute2004–2006
  • Spingomyelinase In Atherosclerosis And Foam Cell BiologyNational Heart, Lung, And Blood Institute2002–2006
  • Macrophage Death In Plaque VulnerabilityNational Heart, Lung, And Blood Institute2005
  • Conference On Cellular Biology Of AtherosclerosisNational Heart, Lung, And Blood Institute2005
  • Macrophage Death And Lipid Metabolism In AtherosclerosisNational Heart, Lung, And Blood Institute2000–2002
  • Form Cell APO (A)/Lp(A) Receptor--Cloning And FunctionNational Heart, Lung, And Blood Institute2000–2002
  • Core--PathologyNational Heart, Lung, And Blood Institute1997–2002
  • Arterial Sphingomyelinase, Proteoglycans And AtherogenesisNational Heart, Lung, And Blood Institute1997–2001
  • Foam Cell APO (A)/Lp(A) Receptor--Cloning And FunctionNational Heart, Lung, And Blood Institute1999
  • Macrophage Cholesterol And Phospholipid Metabolism--Foam Cell NecrosisNational Heart, Lung, And Blood Institute1997–1999
  • Macrophage Cholesterol And Phospholipid Metabolism --Foam Cell NecrosisNational Heart, Lung, And Blood Institute1996
  • ACAT Reactivity In MacrophagesNational Heart, Lung, And Blood Institute1995–1996
  • ACAT Reactivity In MacrophagesNational Heart, Lung, And Blood Institute1988–1994

Hospital Affiliations

Dr. Ira Tabas, Dr. Ira Tabas, MD, Dr. I Tabas, Dr. Ira A. Tabas